Evidence map›Paper›PMID 36078875›Full record

ArticleJournal of clinical medicine2022

A New Deep Learning Algorithm with Activation Mapping for Diabetic Retinopathy: Backtesting after 10 Years of Tele-Ophthalmology.

Alicia Pareja-Ríos, Sabato Ceruso, Pedro Romero-Aroca, Sergio Bonaque-González

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Alicia Pareja-RíosDepartment of Ophthalmology, University Hospital of the Canary Islands, 38320 San Cristóbal de La Laguna, Spain.
Sabato CerusoSchool of Engineering and Technology, University of La Laguna, 38200 San Cristóbal de La Laguna, Spain.
Pedro Romero-ArocaOphthalmology Department, University Hospital Sant Joan, Institute of Health Research Pere Virgili (IISPV), Universitat Rovira & Virgili, 43002 Tarragona, Spain.ORCID 0000-0002-7061-8987
Sergio Bonaque-GonzálezInstituto de Astrofísica de Canarias, 38205 San Cristóbal de La Laguna, Spain.ORCID 0000-0002-7162-0368

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report the development of a deep learning algorithm (AI) to detect signs of diabetic retinopathy (DR) from fundus images. For this, we use a ResNet-50 neural network with a double resolution, the addition of Squeeze-Excitation blocks, pre-trained in ImageNet, and trained for 50 epochs using the Adam optimizer. The AI-based algorithm not only classifies an image as pathological or not but also detects and highlights those signs that allow DR to be identified. For development, we have used a database of about half a million images classified in a real clinical environment by family doctors (FDs), ophthalmologists, or both. The AI was able to detect more than 95% of cases worse than mild DR and had 70% fewer misclassifications of healthy cases than FDs. In addition, the AI was able to detect DR signs in 1258 patients before they were detected by FDs, representing 7.9% of the total number of DR patients detected by the FDs. These results suggest that AI is at least comparable to the evaluation of FDs. We suggest that it may be useful to use signaling tools such as an aid to diagnosis rather than an AI as a stand-alone tool.

Indexed as

artificial intelligencedeep learningdiabetic retinopathytele-ophthalmology

Identifiers

PMID36078875
PMCPMC9456446

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.